dapsone has been researched along with Hematologic Diseases in 12 studies
Hematologic Diseases: Disorders of the blood and blood forming tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "There are no published haematological data on the long-term (more than one year) use of dapsone-pyrimethamine (Maloprim, Folaprim; one tablet a week) for malarial prophylaxis." | 7.67 | Haematological safety of long-term malarial prophylaxis with dapsone-pyrimethamine. ( Cook, IF; Kish, MY, 1985) |
| "There are no published haematological data on the long-term (more than one year) use of dapsone-pyrimethamine (Maloprim, Folaprim; one tablet a week) for malarial prophylaxis." | 3.67 | Haematological safety of long-term malarial prophylaxis with dapsone-pyrimethamine. ( Cook, IF; Kish, MY, 1985) |
| "In 1964, Sweet described an acute febrile neutrophilic dermatosis." | 2.43 | From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. ( Vignon-Pennamen, MD; Wallach, D, 2006) |
| "Dapsone has been the mainstay for the treatment of leprosy since its discovery in the 1940s." | 1.56 | Hematological alterations in lepromatous leprosy: A cross-sectional observational study. ( Awan, KH; Chaudhary, M; Gupta, B; Gupta, S; Patil, S; Raj, AT, 2020) |
| " Dosage data indicated that fatalities had taken higher doses and continued prophylaxis after onset of symptoms." | 1.28 | Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. ( Phillips-Howard, PA; West, LJ, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, B | 1 |
| Gupta, S | 1 |
| Chaudhary, M | 1 |
| Raj, AT | 1 |
| Awan, KH | 1 |
| Patil, S | 1 |
| Watts, PJ | 1 |
| Khachemoune, A | 1 |
| Wallach, D | 1 |
| Vignon-Pennamen, MD | 1 |
| Dao, AH | 1 |
| Gregory, DW | 1 |
| McKee, LC | 1 |
| Vage, C | 1 |
| Saab, N | 1 |
| Woster, PM | 1 |
| Svensson, CK | 1 |
| Tingle, MD | 1 |
| Park, BK | 1 |
| Safrin, S | 1 |
| Finkelstein, DM | 1 |
| Feinberg, J | 1 |
| Frame, P | 1 |
| Simpson, G | 1 |
| Wu, A | 1 |
| Cheung, T | 1 |
| Soeiro, R | 1 |
| Hojczyk, P | 1 |
| Black, JR | 1 |
| Barber, BA | 1 |
| Pegram, PS | 1 |
| High, KP | 1 |
| Wilson, JR | 1 |
| Harris, JW | 1 |
| Phillips-Howard, PA | 1 |
| West, LJ | 1 |
| Cook, IF | 1 |
| Kish, MY | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Trimethoprim / Sulfamethoxazole in the Treatment of Mild-to-Moderate PCP in Patients With AIDS[NCT00000640] | Phase 3 | 290 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for dapsone and Hematologic Diseases
| Article | Year |
|---|---|
Subcorneal Pustular Dermatosis: A Review of 30 Years of Progress.
Topics: Connective Tissue Diseases; Dapsone; Diagnosis, Differential; Glucocorticoids; Hematologic Diseases; | 2016 |
From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research.
Topics: Abscess; Anti-Inflammatory Agents; Arthritis; Case Management; Dapsone; Digestive System Diseases; F | 2006 |
1 trial available for dapsone and Hematologic Diseases
| Article | Year |
|---|---|
Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Clindamycin; Dapsone; Double-Blind Met | 1996 |
9 other studies available for dapsone and Hematologic Diseases
| Article | Year |
|---|---|
Hematological alterations in lepromatous leprosy: A cross-sectional observational study.
Topics: Adult; Case-Control Studies; Cross-Sectional Studies; Dapsone; Erythrocyte Indices; Female; Hematocr | 2020 |
French dapsone survey.
Topics: Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; France; Health Care Surveys; | 2002 |
Specific health problems of Southeast Asian refugees in middle Tennessee.
Topics: Asia, Southeastern; Dapsone; Drug Therapy, Combination; Female; Hematologic Diseases; Hemoglobin E; | 1984 |
Dapsone-induced hematologic toxicity: comparison of the methemoglobin-forming ability of hydroxylamine metabolites of dapsone in rat and human blood.
Topics: Adult; Animals; Ascorbic Acid; Dapsone; Drug Stability; Hematologic Diseases; Humans; Male; Methemog | 1994 |
The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias.
Topics: Animals; Dapsone; Drug-Related Side Effects and Adverse Reactions; Erythrocyte Count; Hematologic Di | 1993 |
Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; CD4 Lymphocyte Count; Clindamyci | 1996 |
Hematologic side-effects of dapsone.
Topics: Adult; Agranulocytosis; Dapsone; Female; Hematologic Diseases; Hematopoietic System; Hemolysis; Huma | 1977 |
Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain.
Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Chemical and Drug Induced Liver Injury; Child; Child, | 1990 |
Haematological safety of long-term malarial prophylaxis with dapsone-pyrimethamine.
Topics: Adolescent; Adult; Age Factors; Antimalarials; Child; Child, Preschool; Dapsone; Drug Combinations; | 1985 |